Department of Cardiovascular Surgery, Gaozhou People's Hospital, Gaozhou, 525200, China.
Department of Cardiovascular Medicine, First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, 014010, China.
Nutr Metab Cardiovasc Dis. 2024 Dec;34(12):2659-2668. doi: 10.1016/j.numecd.2024.08.009. Epub 2024 Aug 24.
Cinnamon has positive effects on markers of cardiometabolic health, including blood pressure (BP), oxidative stress, and inflammation. Despite the evidence accumulated from meta-analysis studies on the effects of cinnamon on these markers, the reported findings are still controversial. This umbrella review was conducted to evaluate the evidence and provide a definitive clarification.
We conducted a systematic search in four scientific databases, including PubMed, Scopus, Web of Science, and Embase electronic databases, up to March 2024 to identify systematic reviews and meta-analyses of randomized clinical trials investigating the impact of cinnamon on blood pressure, oxidative stress, and inflammation. The findings revealed that cinnamon might exert favorable effects on systolic blood pressure (SBP) (ES = -2.36 mmHg; 95% CI: 3.86, -1.40), diastolic blood pressure (DBP) (ES = -1.65 mmHg; 95% CI: 2.41, -0.90), total antioxidant capacity (TAC) (WMD = 0.34; 95% CI: 0.04, 0.64), and interleukin-6 (IL-6) (WMD = -1.48; 95% CI: 2.96, -0.01). However, the results did not show any significant effect of cinnamon on malondialdehyde (MDA) (WMD = -0.47; 95% CI: 0.99, 0.05), C-reactive protein (CRP) (WMD = -1.33; 95% CI: 2.66, 0.00), and intercellular adhesion molecule 1 (ICAM-1) (WMD= 1.53, 95% CI: 12.03, 15.10).
The results of the studies included in this umbrella review support the usefulness of cinnamon consumption in modulating BP as well as improving TAC and IL-6 in metabolic disorders. Due to the limited number of studies, clinical diversity, and other limitations, more high-quality studies must be conducted to provide more precise and comprehensive recommendations.
PROSPERO, CRD42023487350.
肉桂对心血管代谢健康标志物有积极影响,包括血压(BP)、氧化应激和炎症。尽管荟萃分析研究积累了关于肉桂对这些标志物影响的证据,但报告的结果仍存在争议。本伞状评价旨在评估证据并提供明确的澄清。
我们在四个科学数据库中进行了系统检索,包括 PubMed、Scopus、Web of Science 和 Embase 电子数据库,截至 2024 年 3 月,以确定系统评价和荟萃分析随机临床试验,调查肉桂对血压、氧化应激和炎症的影响。研究结果表明,肉桂可能对收缩压(SBP)(ES=-2.36mmHg;95%CI:3.86,-1.40)、舒张压(DBP)(ES=-1.65mmHg;95%CI:2.41,-0.90)、总抗氧化能力(TAC)(WMD=0.34;95%CI:0.04,0.64)和白细胞介素-6(IL-6)(WMD=-1.48;95%CI:2.96,-0.01)产生有利影响。然而,肉桂对丙二醛(MDA)(WMD=-0.47;95%CI:0.99,0.05)、C 反应蛋白(CRP)(WMD=-1.33;95%CI:2.66,0.00)和细胞间黏附分子 1(ICAM-1)(WMD=1.53,95%CI:12.03,15.10)没有显示出任何显著影响。
本伞状评价中纳入研究的结果支持肉桂摄入在调节血压以及改善代谢紊乱时的 TAC 和 IL-6 方面的有效性。由于研究数量有限、临床多样性和其他限制,必须进行更多高质量的研究,以提供更精确和全面的建议。
PROSPERO,CRD42023487350。